中国血液净化 ›› 2018, Vol. 17 ›› Issue (06): 412-415.doi: 10.3969/j.issn.1671-4091.2018.06.013

• 综述 • 上一篇    下一篇

减轻CKD 患者磷肠道负荷的重要环节——药物含磷及低磷/蛋白质比值饮食

林丽萍1,李佳梦1,苏白海1   

  1. 1.  四川大学华西医院肾脏内科
  • 收稿日期:2017-10-11 修回日期:2018-03-22 出版日期:2018-06-12 发布日期:2018-06-20
  • 通讯作者: 苏白海 imsbh@163.com E-mail:suxiaoxi616@gmail.com

The important parts to reduce intestinal phosphorus load in CKD patients: phosphate-containing medications and low dietary phosphate/protein ratio

  • Received:2017-10-11 Revised:2018-03-22 Online:2018-06-12 Published:2018-06-20

摘要: 【摘要】慢性肾脏病-矿物质和骨代谢异常(chronic kidney disease-mineral and bone disorder,CKD-MBD)是慢性肾脏病(chronic kidney disease,CKD)患者常见的并发症之一,控制高磷血症为防治CKD-MBD 的关键。然而,药物作为慢性肾脏病患者磷肠道负荷的潜在来源却常常被忽视。故本文针对药物的磷含量、低磷/蛋白质比值饮食的研究进展予以综述。

关键词: 药物磷含量, 低磷/蛋白质比值饮食, 慢性肾脏病-矿物质和骨代谢异常

Abstract: 【Abstract】Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the common complications in patients with chronic kidney disease (CKD), and the control of hyperphosphatemia is the key to the prevention and treatment of CKD- MBD. However, drugs are often overlooked as the potential sources of phosphorus burden in patients with chronic kidney disease. Therefore, the research progresses in phosphate content of drugs, low dietary phosphorus to protein ratio are reviewed in this article.

Key words: Phosphate content in drug, Low dietary phosphorus to protein ratio, Chronic kidney disease - mineral and bone disorder